eAMS Smartphone App for Asthma
(eAMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone app designed to help manage asthma. Patients fill out a simple questionnaire on their phones, which then provides doctors with recommendations for asthma care. Participants will also use a self-management tool called Breathe. The trial seeks individuals with asthma who have not received an asthma action plan in the last six months. As an unphased trial, this study offers a unique opportunity to contribute to innovative asthma management solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems the focus is on using a smartphone app to manage asthma, so you may not need to change your current medication routine.
What prior data suggests that this app is safe for asthma management?
Research has shown that the Electronic Asthma Management System (eAMS) was tested in earlier studies with good results. This system manages asthma through a smartphone app where patients answer questions about their condition. Doctors then use the collected information to provide asthma care advice.
Although these studies did not provide specific safety data on eAMS, it's important to note that eAMS is an app. It doesn't involve taking new medicines or undergoing medical procedures, which usually reduces the risk of side effects. The main goal is to improve communication between patients and doctors about managing asthma.
Overall, available information suggests that eAMS is easy to use. It is a digital tool designed to enhance asthma care without introducing new medical risks.12345Why are researchers excited about this trial?
The eAMS Smartphone App for Asthma is unique because it integrates technology into asthma management, offering a personalized approach through a smartphone or tablet app. Unlike traditional methods that rely on paper-based action plans and general guidelines, eAMS uses a simple questionnaire to generate tailored asthma care recommendations for clinicians. It also provides patients with a personalized asthma action plan and access to a tool called Breathe, empowering them to manage their condition more effectively. Researchers are excited about this treatment because it has the potential to enhance patient engagement and improve asthma outcomes by providing real-time, personalized care recommendations.
What evidence suggests that the eAMS app is effective for asthma management?
Research has shown that the Electronic Asthma Management System (eAMS), which participants in this trial may use, improves asthma care by using technology to assist in treatment decisions. Regular use of this digital asthma tool has reduced doctor visits and asthma flare-ups. The system includes a smartphone app that provides personalized asthma management plans, leading to better control of asthma symptoms. Studies also indicate that electronic devices for tracking asthma can reduce the need for rescue inhalers and enhance overall asthma management. These findings suggest that tools like eAMS make managing asthma more effective and convenient for patients.26789
Are You a Good Fit for This Trial?
This trial is for asthma patients aged 16 or older, identified by a validated electronic record search. It's open to those who haven't received an Asthma Action Plan (AAP) in the last six months. Pregnant individuals are excluded as AAP recommendations may differ for them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the Electronic Asthma Management System (eAMS) to complete questionnaires and receive asthma care recommendations
Follow-up
Participants are monitored for asthma control, medication changes, and healthcare utilization
What Are the Treatments Tested in This Trial?
Interventions
- eAMS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Unity Health Toronto
Lead Sponsor
Ontario Lung Association
Collaborator